Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71edd34002a6898a2bd9b54abdcae8ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7cc4546d1169e893f775dd3bcde12183 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
filingDate |
2001-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13283717ca6b2ff441bf6c4f6c3ab387 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3745bc922bbe068186586e425285921c |
publicationDate |
2001-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0174364-A2 |
titleOfInvention |
A use of galantamine for the treatment of alzheimer's disease; targeting the underlying cause of the disease |
abstract |
Galantamine has be used in the treatment of a number of chronic diseases. Galantamine has been found to be safe and effective in the treatment of Alzheimer's disease. The therapeutic drugs, including galantamine, that have been used to date for the treatment of Alzheimer's disease were thought to provide only symptomatic relief. It has now been shown that galantamine can be used for the treatment of the underlying cause of the disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2213285-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0174339-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2213285-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8519006-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0174339-A2 |
priorityDate |
2000-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |